Eosinophilic granulomatosis with polyangiitis following flu guard influenza vaccination: A case report

Clin Case Rep. 2023 Nov 25;11(11):e8217. doi: 10.1002/ccr3.8217. eCollection 2023 Nov.

Abstract

Key clinical message: This case highlights a potential association between influenza vaccination and the development of eosinophilic granulomatosis with polyangiitis (EGPA), prompting the need for increased vigilance regarding vaccine-related autoimmune reactions. While causality remains unclear, clinicians should consider this possibility in patients presenting with EGPA-like symptoms shortly after vaccination.

Abstract: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis characterized by tissue infiltration by eosinophils and hyper eosinophilia. We present a case of EGPA in a middle-aged man following influenza vaccination. The patient developed respiratory symptoms, skin lesions, joint pain, and neurological deficits. Diagnostic tests revealed eosinophilia, positive anti-neutrophil cytoplasmic antibodies, and elevated acute phase reactants. This report highlights a potential association between influenza vaccination and EGPA.

Keywords: autoimmunity; eosinophilic granulomatosis with polyangiitis (EGPA); influenza vaccine; vaccination; vasculitis.

Publication types

  • Case Reports